Few moments in the transfer window frustrate fans more than a deal collapsing at the medical stage, after weeks of negotiation and a smiling photo at the airport. Medicals are often treated as a formality, but they are a detailed risk assessment that can renegotiate a fee, change contract terms, or stop a transfer entirely. Understanding what medicals actually check explains why some deals fail and others proceed despite known issues.

A transfer medical is far more than a quick fitness test. It typically includes a review of the player's full injury history, cardiac screening, musculoskeletal examinations, imaging scans of previous injury sites, blood tests, and functional movement assessments. Club doctors look for current injuries, chronic conditions, and structural risks that could affect the player's availability over the length of the proposed contract.

The process usually takes a day or more and involves specialists, including cardiologists and orthopaedic consultants for players with complex histories. Results are compared with the player's previous medical records, which the selling club is expected to disclose, and any discrepancies can raise concerns. The medical is therefore both a health check and a due diligence exercise.

Players fail medicals for several reasons: an undisclosed current injury, a chronic condition that suggests high future injury risk, a cardiac anomaly requiring further investigation, or a previous injury that has not healed as expected. Sometimes the issue is not a fail in absolute terms but a risk the buying club is unwilling to accept at the agreed price, leading to renegotiation rather than outright collapse.

Famous collapsed deals often involve knee or ankle problems discovered on scans, where the buying club's doctors judge that the player is likely to miss significant time. In other cases, a medical reveals a condition that is manageable but requires a modified training programme, and the deal proceeds with adjusted terms, such as a lower fee, a shorter contract, or appearance-based bonuses.

A concerning medical does not always end a deal. Clubs frequently renegotiate: reducing the fee to reflect the risk, inserting clauses that protect the buying club if the player misses a certain number of matches, or shortening the contract so the club is not committed long-term. Insurance also plays a role, with clubs insuring players against career-ending injury, and medical findings affecting premiums.

Players can also seek second opinions, undergo further tests, or complete rehabilitation before a deal is revived. Some transfers collapse in one window and succeed in the next after treatment and a clean bill of health, showing that a failed medical is a risk assessment at one moment, not a permanent judgement on a player's career.

Medical information is sensitive, and clubs handle it under strict confidentiality, sharing only what is necessary for the transfer decision. Players have rights over their medical data, and disputes can arise when a club is accused of using medical findings to lower a price unfairly. Governing bodies and player unions increasingly emphasise that medicals should protect player welfare, not just club finances.

For fans, the lesson is that a collapsed medical is rarely a simple story of a player being unfit. It reflects a club's risk appetite, the length and value of the proposed contract, and medical evidence that the public never sees. A deal that collapses may protect both the club and the player from a costly mistake.

Football transfer medicals are detailed risk assessments covering injury history, cardiac health and long-term fitness, and they can collapse, renegotiate or reshape a deal. A failed medical reflects risk at a specific price and contract length, not necessarily the end of a player's career.